CEO Brady Granier of of BioCorRx, Inc. returns to the show to discuss new board member additions, recent private placement, and plans to up list to the NASDAQ.
ANAHEIM, CA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and…
VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) -- New Pacific Metals Corp. (TSX-V:NUAG) (OTCQX:NUPMF) (the “Company”) is pleased to announce the preliminary results of the first metallurgical test work…
CEO Brady Granier and CFO Lourdes Felix of BioCorRx, Inc., talk about details of their NIDA grant application approval, recent reverse stock split, and plans for the development of BICX102.
CEO Brady Granier of BioCorRx, Inc., gives an update on addiction recovery treatment programs, NIDA funding application, and medication assisted solutions.
CEO Brady Granier of BioCorRx, Inc., talks about out patient procedure to reduce physical cravings, FDA guidance for development plan, and behavioral programs to treat addiction.
CEO Brady Granier of BioCorRx, Inc., talks about various treatment options for addiction recovery.
CEO Brady Granier of BioCorRx, Inc., gives an update on addiction treatment solutions and upcoming meeting with the FDA.
CEO Brady Granier of BioCorRx, Inc., talks about addiction treatment solutions.